Skip to content
777 Sourcing.

Capability

GDF11 signaling pathway research

Suppliers
1
States & provinces
1
Countries
1

1 gdf11 signaling pathway research supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

ALEVIAN, INC.

LEXINGTON, MA

Alevian is a preclinical-stage biotech developing regenerative therapeutics that target biological mechanisms promoting repair and regeneration. Its lead program, ALE-001, is an engineered recombinant form of GDF11 designed to treat acute ischemic stroke by reducing inflammation, promoting neovascularization, stimulating neurogenesis, and improving functional recovery, with a treatment window extending to 3 days. ALE-001 is progressing toward first-in-human studies, with additional programs in intracerebral hemorrhage, traumatic brain injury, chronic str

biologics developmentpreclinical researchtranslational research

Compiled from public sources

Related capabilities

Other processes offered by the shops that list GDF11 signaling pathway research.

Browse all capabilities